Thus, Trim72 could be a useful therapeutic target in obesity, IR, and T2DM because insulin sensitivity and glucose uptake is highly increased in the enhanced skeletal muscle. Here, TRIM72 is linked to obesity due to melanocortin 4 receptor deficiency.